Navigation Links
Proper Ratio Of Omega-3 And Omega-6 Could Reduce Prostate Cancer Growth

According to a study conducted by Dr. William Aronson, a professor in the department of urology at the David Geffen School of Medicine at UCLA// in mice it was found that a proper balance in th ratio of omega-3 and omega-6 fatty acids reduced the prostate cancer growth rates.

The study results were published in the journal Clinical Cancer Research. He said that Americans had an increased amount of omega-6 fatty acids containing diet such as corn, safflower oils and red meats. On the other hand omega-3 fatty acids are found in cold-water fish like salmon, tuna and sardines. The researcher said that by eating a healthy ratio of these two types of fatty acids could make a difference in reducing prostate cancer growth. But further studies are essential to prove that this works in case of humans.

Statistics show that the incidence of the disease is increasing with a rise of 1.7 % over 15 years. Prostate specific antigen (PSA) is a protein that is used as a marker for the disease – higher levels are associated with a higher risk of prostate cancer. According to the study it was found that eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) lead to the development of more anti inflammatory prostaglandins which reduce the growth of the prostate tumor.


'"/>




Page: 1

Related medicine news :

1. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
2. Geriatric Patients With Chronic Kidney Disease May Not Be Treated Properly
3. Stem Cells, Tumor Cells Share Similar Properties: Scope For Treatment and Prevention?
4. Fruits And Vegetables Have Arthritis Risk Reducing Property
5. Proper Validation of Generic Drugs Could Save Millions of AIDS Patients
6. Proper Treatment of Hypothyroidism Found To Prevent Heart Diseases
7. Colon Cancer Patients Not Receiving Proper Treatment
8. Proper Diet Can Counter Macular Degeneration
9. Scots Do Not Have Access To Proper Dental Care
10. Risk Of Stroke Can Be Lessened By Proper Diet
11. Cancer-causing Property Of Teflon Leaves US Regulators Concerned
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2017)... ... August 17, 2017 , ... An August 2 article ... obtaining plastic surgery, largely influenced by the growing popularity of “pretty boys” in both ... notes that standards of male appearance are changing not only in the Asian nation, ...
(Date:8/17/2017)... ... 2017 , ... Pot Valet is a leading provider of premium medical-grade cannabis ... state, and soon, every state in the country, the company offers patients safe, legal, ... altogether. , According to Pot Valet, all California patients have the legal ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... A recent ... to the biopharmaceutical industry in 2016 cited deficiencies in data integrity. The FDA outlines ... Part 11 ruling. , Presented as part of the Beckman Coulter Life ...
(Date:8/16/2017)... Los Angeles, California (PRWEB) , ... August 16, 2017 , ... An August 3rd ... patients that was the subject of a report in JAMA (the Journal of the American ... (BMIs) above 50 were able to achieve BMIs under 30, when compared to patients with ...
(Date:8/16/2017)... ... August 16, 2017 , ... For the second ... England student to educate the public on the impact of concussions. Brooke Mills, ... first-ever National Concussion Awareness Day. , Brooke is working diligently is to raise ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: ... quarter ended June 30, 2017, and updated its financial ... For the fiscal third quarter, Hill-Rom reported ... per diluted share in the prior-year period. These results ... per diluted share primarily related to the non-cash write-down ...
(Date:7/27/2017)... Pharmaceutical Services, Inc. (NYSE: WST ) today ... updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, a record ... at constant currency (organic) grew by 3.9%. ... $0.60 in the prior-year quarter. Second-quarter 2017 adjusted diluted ...
(Date:7/26/2017)... July 26, 2017 Sancilio Pharmaceuticals Company, Inc. ... clinical trial evaluating Altemia TM , an oral therapy ... Sickle Cell Disease (SCD). The SCOT Trial, is a ... and safety of Altemia TM in pediatric patients ... US IND 125274. ...
Breaking Medicine Technology: